Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-13

Clinical Trial Update: Perinatal Arterial Stroke Treated With Stromal Cells Intranasally [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial update reports results for intranasal administration of stromal cells to treat perinatal arterial ischemic stroke and neonatal arteri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stromal cells (intranasal) (mesenchymal stromal cells)

Snippet

Sponsor: UMC Utrecht | Conditions: Perinatal Arterial Ischemic Stroke, Neonatal Stroke | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-13